Trial intelligence / Profile preview

PK/PD of Metformin IR in Healthy Volunteers

NCT02712619Phase 1Completed

Sponsor
Seoul National University Hospital
Start
May 2014
Primary completion
Sep 2014
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Maximum plasma concentration, Area under the metformin concentration curve and 1 more. Started May 2014; status: completed.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02712619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02712619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call